Product Program year 2020 Source: CMS Open Payments

Zelnorm

Drug Irritable Bowel Syndrome

NDC 0525-0971-10

Open in the dashboard

General payments

$59,146

1,055 payments

Research payments

$0

0 payments

Through program year 2020, $59,146 in general payments and $0 in research payments were reported against Zelnorm (Irritable Bowel Syndrome).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $59,146 1,055

Breakdown

Who paid General payments · program year 2020
  1. Alfasigma USA, Inc. $59,146 1,055 payments
Top recipients General payments · program year 2020
  1. Darren Brenner Gastroenterology · Chicago, IL $6,585 11% · 8 payments
  2. Brooks Cash Gastroenterology · Houston, TX $5,835 10% · 7 payments
  3. William Chey Gastroenterology · Ann Arbor, MI $4,200 7% · 2 payments
  4. David Leff Gastroenterology · Mesa, AZ $4,003 7% · 9 payments
  5. Myron Brand Gastroenterology · New Haven, CT $2,500 4% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Gastroenterology Internal Medicine $53,571 91% · 514 practitioners
  2. Family Medicine $1,581 3% · 85 practitioners
  3. Internal Medicine $1,575 3% · 85 practitioners
  4. Colon & Rectal Surgery $226 <1% · 11 practitioners
  5. Anatomic Pathology & Clinical Pathology Pathology $200 <1% · 2 practitioners

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Michigan $10,977 19% · 13 recipients
  2. New York $8,459 14% · 121 recipients
  3. Virginia $7,267 12% · 30 recipients
  4. Arizona $4,731 8% · 37 recipients
  5. Texas $3,192 5% · 87 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,055 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record